Coatue Management

Sixth Street is a global investment firm with over $50 billion in assets under management and committed capital. The Sixth Street Healthcare and Life Sciences team provides strategic growth capital tailored to healthcare and pharma business timelines including to develop or launch new medicines, make asset acquisitions and fund strategic projects. Select current and past representative Sixth Street Healthcare and Life Sciences investments include Biohaven, Caris Life Sciences, Clovis, DrFirst, Immunogen, Ironwood, MDLIVE and Nektar. Sixth Street’s long-term oriented, highly flexible capital base and “One Team” cultural philosophy allow the firm to invest thematically across sectors, geographies and asset classes. Founded in 2009, Sixth Street has more than 320 team members including over 145 investment professionals operating from nine locations around the world *

	Start	2021-05-11 existent
	Industry	finance
	Person	Weiner, Aaron (Coatue Management 202110 Managing Director + Head of Healthcare)


Basic data	Employees	n. a.

		* Document for »About Section«: Caris Life Sciences Inc.. (5/11/21). "Press Release: Caris Life Sciences Raises $830 Million in Growth Equity Capital to Continue to Expand its Precision Medicine Platform". Irving, TX.

		Record changed: 2024-12-01